Heterocyclyl compounds

Details Heterocyclyl compounds Heterocyclyl compounds

2009-07-08

2011-12-06

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S218000, C514S222500, C514S253010, C514S253120, C540S489000, C540S492000, C544S003000, C544S006000, C544S230000, C544S360000, C544S363000, C544S364000, C544S372000

Reexamination Certificate

active

08071586

ABSTRACT:
The invention is concerned with novel heterocyclyl compounds of formula (I)wherein A, X, Y1, Y2, Y3, R3, R4, R5, R6, R7, R8, R9, R10, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.

REFERENCES:
patent: 6645958 (2003-11-01), Weikert et al.
patent: 2007/0249589 (2007-10-01), Aebi et al.
patent: 1627876 (2006-02-01), None
patent: WO 00/32590 (2000-06-01), None
patent: WO 2008/136754 (2008-11-01), None
Vice et al., J. Org. Chem., 66, pp. 2487-2492 (2001).
Brown Ripin et al., Tetrahedron Letters, 41, pp. 5817-5819 (2000).
Mori, K., Tetrahedron, 39, pp. 3107-3109 (1983).
Avenoza et al., Synthesis, pp. 1146-1150 (1997).
Koshti et al., Tetrahedron Letters, 35, pp. 5157-5160 (1994).
Sugiyama et al., J. Am. Chem. Soc., 129, pp. 14811-14817 (2007).
Radosevich et al., J. Am. Chem. Soc, 127, pp. 1090-1091 (2005).

Affiliated with

Also associated with

Rating

Heterocyclyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4314444